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Abstract
Background: Information on hypertension in the very elderly is sparse. Until recently evidence of
benefits from pharmacological treatment was inconclusive. We estimated the prevalence of
hypertension in subjects aged 80 or more, the proportion of awareness, treatment and control.
Explanatory variables associated with good control were also studied.
Methods: Cross sectional, population-based study, conducted in Martorell, an urban Spanish
municipality, in 2005. By simple random sampling from the census, 323 subjects aged 80 or more
were included. Patients were visited at home or in the geriatric institution and after giving informed
consent, the study variables were collected. These included: supine and standing blood pressure
and information about diagnosis and treatment of hypertension. The estimation and 95%
confidence interval were obtained and a logistic regression model was used to study explanatory
variables associated with blood pressure below 140/90 mm Hg.
Results: The prevalence of hypertension was 72.8% (95%CI: 69.5 – 76.6%) and 93% of the patients
were aware of this condition, of whom 96.3% (95%CI: 93.65 – 97.9%) had been prescribed
pharmacological treatment and 30.7% (95%CI: 25.8 – 36.1%) had blood pressure below 140/90 mm
Hg. Some of the patients (43%) had one antihypertensive drug and 39.5% had two in combination.
Explanatory variables associated with blood pressure below 140/90 mm Hg included prescription
of a diuretic, OR: 0.31 (95%CI: 0.14 – 0.66), and history of ischemic heart disease, OR: 0.21 (95%CI:
0.1 – 0.47).
Conclusion: The prevalence of hypertension in population aged 80 or more was over 70%. Most
patients were aware of this condition and they had antihypertensive medication prescribed.
Approximately one third of treated patients had blood pressure below 140/90 mm Hg. Patients
with heart disease and with diuretics had more frequently blood pressure below this value.
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Background
In Spain 655,924 men and 1,247,295 women were 80
years of age or more in 2005, which represents 3.8% and
5.5% of total male and female Spanish population [1].
Life expectancy at age 80 was 9.2 years for women and 7.6
for men [2]. An increase of this age group is expected
because of the progressive aging of the population and the
increase in life expectancy. Cerebrovascular diseases are
the main cause of death for this age group and arterial
hypertension is the principal risk factor for this condition.
In several studies the prevalence of hypertension in Span-
ish geriatric population ranged from 65% to 76%, and
they include people aged over 60 years [3,4], 65 [5] or 75
[6].
Until very recently evidence that treating patients 80 years
of age or older is beneficial was inconclusive [7-9]. Most
clinical trials on hypertension conducted in geriatric pop-
ulation included a low proportion of people aged 80 or
more [10-14]. In 2008 the results of HYVET clinical trial
were published [15]. For the first time benefits of active
treatment (indipamide with or without perindopril) were
proved for the very elderly.
In our country there is little information available about
hypertension in the very elderly. The objectives of the
study were to estimate the prevalence of hypertension in
subjects aged 80 years or more, awareness, treatment and
control. Explanatory variables associated with good con-
trol were also studied.
Methods
Setting and subjects
The study is cross sectional, population-based and it was
conducted in 2005 in Martorell. It is an urban municipal-
ity close to Barcelona, Spain, with 25,718 inhabitants
(879 aged 80 or more). Inclusion criteria were people
aged 80 years or more, living at home or in geriatric insti-
tutions, included in the census of the municipality who
gave informed consent to participate in the study. Exclu-
sion criteria included disorders that made impossible to
measure blood pressure, extreme mobility alteration and
terminal patients.
By simple random sampling 323 subjects were selected.
Sample size was calculated assuming a proportion of 0.7,
with 0.05 precision and a confidence level of 95%. Lost
subjects were replaced.
Data retrieval and statistical analysis
Randomized patients were contacted and visited at home
or in their geriatric institution by a nurse or physician,
where data were collected. Except for the first 10 patients
visited by a nurse, the subjects were visited by physicians,
all of them members of the research team. Measurements
were standardized. Patients who gave informed consent
were included in the study. Variables studied were: Demo-
graphic (age, gender, residence), Diagnostic blood pres-
sure (DBP) for those who were not previously diagnosed
hypertension, control blood pressure (CBP) for previ-
ously known hypertensive patients, standing blood pres-
sure (to detect orthostatic hypotension), prescribed
antihypertensive medication, cardiovascular risk factors
(tobacco, hypercholesterolemia, type 2 diabetes mellitus)
and cardiovascular disease (cerebral vascular disease, cor-
onary disease, peripheral vascular disease). The Barthel
index was used to rate ability to perform activities of daily
living. It is a 10 item scale with a highest possible score of
5 to 15 points on each item [16]. It gives a total score from
0 (full dependence) to 100 (independence).
Blood pressure was ascertained under standardized condi-
tions. After a 5 minute-rest blood pressure was measured
in the seated position, using appropriately sized cuffs and
calibrated and validated automatic devices (HEM-711,
OMRON). Feet were flat on the floor and arm supported
at heart level. Contralateral arm was verified.
Measurement of Diagnostic blood pressure: patients who
were not previously diagnosed hypertension had two
measurements separated one another more than 2 min-
utes, in three different days at least 7 days apart. Diagnos-
tic blood pressure was the mean value. For blood pressure
measurements and criteria for definition of hypertension
we followed the hypertension guidelines of the Catalan
Society of Family and Community Medicine [17]. These
criteria are similar in most international guidelines. The
patient's physician was informed about new diagnosis of
hypertension. Research carried out was in compliance
with the Helsinki Declaration. The project was aproved
and granted by the research board of the Catalan Society
of Family and Community Medicine.
Measurements of Control blood pressure: patients who
were aware of this condition had two blood measure-
ments separated one another more than 2 minutes. Mean
value was considered.
Hypertension was defined as systolic blood pressure
greater than or equal to 140 mm Hg or diastolic blood
pressure greater than or equal to 90 mm Hg, or receiving
medication specifically for the indication of hypertension.
Control was considered acceptable when systolic blood
pressure was less than 140 mm Hg and diastolic blood
pressure less than 90 mmHg among treated hypertensive
patients.
Blood pressure was also measured in the standing posi-
tion. Orthostatic hypotension was considered when a
reduction of at least 20 mm Hg in systolic blood pressureBMC Geriatrics 2009, 9:16 http://www.biomedcentral.com/1471-2318/9/16
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or at least 10 mm Hg in diastolic blood pressure was
observed within 3 minutes of standing up [18]. Pulse
pressure was considered as the difference between systolic
and diastolic blood pressure.
The estimation and 95% confidence interval were
obtained for the prevalence of hypertension, awareness
and control. Logistic regression models with forward step-
wise selection of variables were used to study explanatory
variables associated with blood pressure below 140/90
mm Hg. Independent variables studied were age, gender,
functional status, residence at home or in geriatric institu-
tions and cardiovascular disease.
Results
Description of studied population
A total of 447 individuals aged 80 and over were ran-
domly selected from the municipal census. The following
did not participate in the study for the following reasons:
48 had already died, 35 refused, 30 could not be con-
tacted, 9 did not live in the municipality and 2 because of
severe dementia. Response rate was 81% (399 people
were contacted and 323 were included).
The total number of subjects included was 323. The per-
centage of women was 62.5%, mean age 84.9 (S.D: 3.6).
Most of them lived at home (91.6%) and 8.4% lived in
geriatric institutions. According to their functional status
44.3% were independent (scored 100 in Barthel index)
and 41.2% had mild dependence (scored 60 to 99).
The prevalence of other cardiovascular risk factors was:
diabetes mellitus type 2 (20.7% of the subjects), hyperlip-
idemia (35%) and 3.4% were current smokers. The preva-
lence of ischemic heart disease was 13%, stroke 17.3%
and peripheral vascular disease 11.1%.
Hypertension: prevalence and management
In table 1, total prevalence of hypertension is presented as
well as the percentage of patients who were aware of it,
had pharmacological treatment and had blood pressure
below 140/90 mm Hg. The number of active ingredients
prescribed to patients who were diagnosed hypertension
was: 0 (3.7%), 1 (43.1%), 2 (39.5%), 3 (13.5%) and 4
(0.3%). In tables 2 and 3 the prescription of main thera-
peutic groups and combinations is presented.
The percentage of patients with hypertension diagnosis
with systolic blood pressure below 140 mm Hg and
diastolic pressure below 90 mmHg was 30.7% (95% CI:
25.8 – 36.1%). Explanatory variables associated with
blood pressure below 140/90 mm Hg: there was good
control in 35.4% of patients who were prescribed a diu-
retic and in 21.6% of patients without this medication
(OR: 0.31; 95%CI: 0.14 – 0.66). The percentage of
patients with ischemic heart disease with good control
was higher (57.6%) than that of patients without this con-
dition (26.6%), odds ratio: 0.21 (95%CI: 0.1 – 0.47). Age
and sex were not statistically significant.
Pulse pressure was 65 mm Hg or higher in 65% of subjects
(95% CI: 60.5 – 69.3%); in 72.3% (95% CI: 67.3 –
76.9%) of patients with hypertension and in 45.4% of
people without this condition (95% CI: 60.5 – 69.3%).
Orthostatic hypotension was present in 9.6% of patients
(95% CI: 7.2 – 12.6%); in 8.3% (5.7 – 11.9%) of patients
with hypertension and 12.4% (8–18.7%) of patients
without it.
Discussion
The prevalence of hypertension in this population aged
80 or more is very high, it exceeds 70% and most of the
patients (93%) are aware of this condition. Most subjects
known to be hypertensive have pharmacological treat-
ment (96%), even though at the time data were collected
there was no clear evidence of the benefits in this age
group. However, only 31% of the patients aware of this
condition had blood pressure below 140/90 mmHg.
Another study in elderly population conducted in Spain
has a similar prevalence of hypertension [3]. However,
awareness and treatment is higher in our study. Banegas
Table 1: Prevalence of hypertension, awareness, treatment and control in a population-based study conducted in a Spanish 
municipality with patients aged 80 and over.
Percentage 95% CI-lower 95% CI-upper
Total prevalence of hypertension 72.8 69.5 76.6
Awareness 92.7 89.5 95.1
Pharmacological treatment 96.3 93.6 97.9
Blood pressure below 140/90 mmHg 30.7 25.8 36.1
Total prevalence of hypertension, awareness (out of total hypertension), treatment (out of diagnosed patients) and blood pressure below 140/90 
(out of diagnosed patients).BMC Geriatrics 2009, 9:16 http://www.biomedcentral.com/1471-2318/9/16
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who included patients over 60 found a percentage of
awareness of 65% [3], (while ours was 92%) and 55.3%
of treatment (96% in our study). The reason might be
because in our study the subjects are older, and the very
elderly might have more contact with the health system
and so hypertension could be more easily detected and
treated. Martinez Pastor studied patients aged over 75
controlled in primary care in Spain, and 92% were pre-
scribed antihypertensive treatment [6].
The very old have been under-represented in many past
randomized clinical trials [8]. As a result there is a lack of
evidence of the benefit of many pharmacological treat-
ments addressed to this age group. The results of HYVET,
a clinical trial enrolling hypertensive patients aged 80 or
more, have been published recently [15]. The benefit of
active treatment (indipamide with or without perindo-
pril) for the very elderly has been proved for the first time.
However, when we obtained the data for the study this
Table 2: Prescription of therapeutic groups in patients aged 80 and over in a Spanish municipality.
Treatment Percentage 95% CI-lower 95% CI-upper
Diuretic 68.1 60.6 71.1
ACE inhibitor 41.3 35.9 46.9
Calcium antagonist 23.4 19 28.4
Angiotensin II antagonist 23.4 19 28.4
Beta blocker 7.3 4.9 10.8
Alpha1 blocker 4.6 2.8 7.5
Others 0.9 0.3 2.7
Percentage of patients with prescription of the main pharmacological groups.
ACE-Inhibitor: angiotensin-converting enzyme inhibitor.
Table 3: Prescription of different combinations and monotherapies in patients aged 80 and over in a Spanish municipality.
Treatment Percentage 95% CI-lower 95% CI-upper
Diuretic + ACE inhibitor 18.4 14.4 23.1
Diuretic 13.8 10.4 18.1
ACE inhibitor 12.4 9.2 16.5
Diuretic + AA 10.6 7.6 14.5
Calcium antagonist 7.4 14.9 10.8
AA 6.9 4.6 10.3
Diuretic +ACE-I +calcium antagonist 6.5 4.2 9.7
Diuretic + calcium antagonist 5.1 3.1 8.1
Diuretic + beta blocker 2.8 1.4 5.2
Diuretic + AA + calcium antagonist 2.3 1.1 4.6
Others 13.8 9.9 19.0
Most common pharmacological combinations prescribed.
ACE-I: angiotensin-converting enzyme inhibitors. AA: angiotensin II antagonists.BMC Geriatrics 2009, 9:16 http://www.biomedcentral.com/1471-2318/9/16
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information was not available. Considering the lack of
evidence clinicians had about the benefits of treatment, it
is interesting to point out that most of the patients had
antihypertensive medication prescribed and more than
half of them had a combination of at least two drugs.
Probably the patients started medication when they were
younger and they simply did not discontinue their treat-
ment when they became very old.
Results from HYVET are probably not enough to answer
all questions about treatment of the very elderly with
hypertension. There should be caution to extrapolate
results to patients in this age group who are more frail
than those in the trial, and also to other antihypertensive
drugs than those used in the study. Thiazide diuretics in
the very elderly may be more prone to metabolic altera-
tions, such as hypokalemia, which can predispose
patients to arrhythmias and possibly sudden death.
Results from HYVET support a target blood pressure of
150/80 mmHg, whether further reduction is beneficial
still needs to be established.
The percentage of elderly hypertensive patients with
blood pressure below 140/90 mm Hg is also around 30%
in other studies conducted in Spain [3,6,19] and in other
countries [20]. Lloyd-Jones found the prevalence of con-
trol to decline with age, especially in women [20]. Patients
aged 70 and older are less likely to control hypertension
than younger groups [21]. The population we studied was
homogenous in age and perhaps for this reason this factor
was not significant in the regression model. In Spain, the
frequency of control of hypertension in adults is higher
than that in our study. It ranges from 36.1 to 41.4% [22-
24]. Clinicians may be reluctant to treat older patients as
aggressively because of perceived lower benefits or possi-
ble increased risk of adverse events. Under certain circum-
stances treatment might be more aggressive. Thus, we
found patients with history of ischemic heart disease
more frequently with good control. A French study con-
ducted with non-institutionalized subjects aged 65 years
and older also found a higher good control in patients
with previous cardiovascular events [25].
The frequency of orthostatic hypotension in hypertensive
patients increases with advancing age and with systolic
blood pressure. It may be present in 5% to 14.6% of
patients with hypertension, although a minority has
orthostatic symptoms [26]. It is associated with an
increased rate of falls, myocardial infarction, transient
ischemic attack and ischemic stroke [27]. Antihyperten-
sive drugs may induce orthostatic hypotension or aggra-
vate it when pre-existent [28]. This condition might affect
the prescription of antihypertensive drugs or the adher-
ence of patients to medication and, and thus decrease the
optimal control of hypertension in this age group.
Our study is population-based, and it includes both peo-
ple who live in their home and also in geriatric institu-
tions. However an important number of randomized
people had already died when they were contacted or
refused to take part in the study. This limits to some extent
the extrapolation of our results.
The sample was obtained from an urban municipality,
Martorell. So data are valid for this municipality. How-
ever, similar results might be obtained in other urban
populations in Spain. For rural areas, prevalence of hyper-
tension in this age group might be similar, but awareness,
treatment and control may be different because of differ-
ences in access to health services.
Although regression models were used to identify inde-
pendent factors for blood pressure control, it was a sec-
ondary endpoint of the study. Sample size calculations
were based to estimate prevalence of hypertension. Statis-
tical power might be insufficient to identify some factors.
Some factors that might be relevant were not considered,
such as dementia because some patients with this condi-
tion were excluded. Renal failure is often undetected in
primary care [29] and for this reason this variable was not
collected.
Conclusion
The prevalence of hypertension in population aged 80 or
more is over 70%. Most of the people are aware of this
condition. Even though at the time data were collected
there was no clear evidence of the benefits from antihy-
pertensive medication in this age group, most of the
patients had pharmacological treatment. Half of the sub-
jects had two or more drug products and the most com-
mon treatment included diuretic combined with
angiotensin converting enzyme inhibitors. Approximately
one third of treated patients had blood pressure below
140/90 mm Hg and patients with heart disease and receiv-
ing diuretics had better control of hypertension.
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